• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Ainos, Inc. - warrants (NQ: AIMDW )

    0.0700 UNCHANGED
    Streaming Delayed Price Updated: 10:02 AM EDT, May 20, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 0.0700
    Bid (Size) 0.0407 (3)
    Ask (Size) 0.0769 (5)
    Prev. Close 0.0700
    Today's Range 0.0700 - 0.0700
    52wk Range 0.0350 - 0.5730
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Ainos Reports First Quarter 2024 Financial Results
    Via ACCESSWIRE
    Ainos Raises $9 Million in Growth Capital with Existing Shareholder
    Via ACCESSWIRE

    Performance

    YTD
    -60.76%
    -60.76%
    1 Month
    -2.23%
    -2.23%
    3 Month
    -9.79%
    -9.79%
    6 Month
    -84.44%
    -84.44%
    1 Year
    -72.00%
    -72.00%

    More News

    Read More
    Ainos Reports Full Year 2023 Financial Results
    Via ACCESSWIRE
    Ainos Submits Clinical Hold Complete Response to US FDA to Resolve the Deficiencies on Investigational New Drug Phase II Trial of its VELDONA Formulation Against Mild COVID-19 Symptoms
    Via ACCESSWIRE
    Ainos, Inc. to Present at Small-Cap Growth Virtual Investor Conference February 7th
    From Virtual Investor Conferences
    Via GlobeNewswire
    Ainos Announces $1.75 Million Follow-On Funding
    Via ACCESSWIRE
    Ainos Announces Successful Manufacturing of VELDONA GMP Clinical Batch by Swiss Pharmaceutical
    Via ACCESSWIRE
    Ainos Reports Third Quarter 2023 Financial Results
    Via ACCESSWIRE
    Ainos Announces Placement of Initial $3 Million Tranche of $10 Million Private Placement
    Via ACCESSWIRE
    Ainos Regains Compliance with Nasdaq Minimum Bid Price Requirement
    Via ACCESSWIRE
    Ainos, Nisshinbo Micro Devices and Inabata Initiate Phase 2 of VOC Co-development Powered by AI Nose, Accelerating the Digitalization of Smell
    Via ACCESSWIRE
    Ainos, Inc. Announces Stock Consolidation
    Via ACCESSWIRE
    Ainos Announces Positive Data Reported from its Clinical Studies for VELDONA as Potential Treatment of Oral Warts in HIV-Seropositive Patients, an Orphan Drug Designated by the FDA
    Via ACCESSWIRE
    Ainos’ VELDONA Granted Orphan Drug Designation by U.S. FDA for Potential Treatment of Oral Warts in HIV-Seropositive Patients
    Via ACCESSWIRE
    Ainos Commences Shipping its VELDONA Pet Cytoprotein Supplements in Taiwan
    Via ACCESSWIRE
    Ainos Reports Second Quarter 2023 Financial Results
    Via ACCESSWIRE
    Ainos Celebrates First Listing Anniversary on Nasdaq
    Via ACCESSWIRE
    Ainos Issues Mid-Year Business Update Letter to Shareholders
    Via ACCESSWIRE
    Ainos Partners with Nisshinbo Micro Devices and Inabata to Co-Develop VOC Sensing Platform For Broader Industry Adoption
    Via ACCESSWIRE
    Ainos Provides Insights Into Its AI Nose Technology
    Via ACCESSWIRE
    Ainos Completes VELDONA Pet Line-Up by Launching New VELDONA Pet Shiny and Slim in Push Towards $20M Revenue Target
    Via ACCESSWIRE
    Ainos Launches New VELDONA Pet Lohas and Soothing Health Supplements, Catalyzing Its Drive to $20M Sales Target
    Via ACCESSWIRE
    Ainos Launches VELDONA Pet Cytoprotein Health Supplement Targeting $20M in Sales
    Via ACCESSWIRE
    Ainos Appoints Amanda Sung as New Chief Financial Officer
    Via ACCESSWIRE
    Ainos Reports First Quarter 2023 Financial Results
    Via ACCESSWIRE
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.